Undiagnosed Rare Disease Program at Indiana University School of Medicine

Erin Conboy studied biology at Grinnell College in Iowa, then medical school in Hersey, Pennsylvania and finally finished her training at Mayo Clinic in Rochester, Minnesota. She is a clinical and metabolic genetics physician and pediatrician with a special interest in the diagnosis of rare disease. She is the director of the Undiagnosed Rare Disease Clinic at IU School of Medicine and IU Health. She has two sons and enjoys practicing Brazilian Jiu-jitsu with her family.

Dr. Francesco Vetrini, PhD, received his doctorate in Medical Genetics from the Second University of Naples in Italy and then went on to complete a postdoctoral fellowship at Baylor College of Medicine in Houston, TX.

Vetrini spent more than four years as the Lead Clinical Genomics Scientist at Baylor Genetics before joining IU School of Medicine in 2018 as an ABMGG fellow in the Department of Medical and Molecular Genetics. 

As a genomics scientist with expertise in rare disease and new gene discovery, he was recruited to help Dr. Conboy launch the Undiagnosed Rare Disease Clinic. 

His primary responsibilities as the clinic's co-director include the development of protocols for genomic assessment of patients by integrating genomics, transcriptomics, and proteomics, the formation of collaborations for functional studies of candidate genes and variants and co-leading the medical genetics genome board with Dr. Conboy.

Vetrini leads the genomic variant analysis and interpretation, which is completed by a multidisciplinary team that discusses the final interpretation before making recommendations in a final report.

Vetrini's overarching goal is to end the diagnostic odyssey of patients and families by utilizing an integrated multi-omics approach that will improve our understanding of the molecular basis of genetic disorders, resulting in better patient care and conclusive answers for families.

Lili Mantcheva earned her MPH degree in Social and Behavioral Sciences from the Richard M. Fairbanks School of Public Health Indianapolis and her undergraduate degrees in Chemistry and German from Butler University. Lili has previous experience in various healthcare and public health settings, more specifically as a clinical research coordinator at the Indiana University Neuroscience Center, focused on Alzheimer’s disease research and most recently as a health programs director for a local non-profit organization in Indianapolis. Currently, as the Project Manager for the Undiagnosed Rare Disease Clinic, she is responsible for the day-to-day operational organization, overall framework and protocol development, and patient consenting and coordinating during clinic visits. In her free time, she likes to travel, play tennis, walk/hike outdoors, read, and spend time with her family and friends.

Kayla Treat is a pediatric genetic counselor with IU Health and IU School of Medicine. She enjoys seeing a wide variety of clinical indications in the general genetics clinics. She graduated from the IU Genetic Counseling Graduate Program in 2013 and initially accepted a pediatric genetic counseling position at Washington University School of Medicine in St. Louis where she worked in several multidisciplinary clinics at St. Louis Children’s Hospital. She moved back to Indianapolis in October 2014 to accept her current position, and she has loved seeing the growth of the department over the past several years. In 2019 she accepted a new role within the department as the genetic counselor with the Undiagnosed and Rare Disease Clinic. This role felt like a natural fit given her interest in complex genetic syndromes, and she looks forward to seeing the expansion of the clinic over time. She also enjoys working as a clinical supervisor for the IU Genetic Counseling program and recently transitioned to a role as co-course instructor for the medical genetics clinical rotations.

Khurram Liaqat, PhD, is a postdoctoral clinical genomic scientist at the Undiagnosed Rare Disease Clinic. Dr. Liaqat’s primary research interests include rare genetic disorders. 

Dr. Liaqat earned his PhD in Biotechnology (Human Molecular Genetics) and MS in Molecular Biology at Quaid-i-Azam University, Pakistan. During PhD, he spent about two years as a predoctoral fellow at Dr. Suzanne M. Leal’s lab at the Department of Molecular and Human Genetics, Baylor College of Medicine in Houston, TX. He has also completed two years of postdoctoral fellowship at Dr. Leal’s lab at the Center for Statistical Genetics, Department of Neurology, Columbia University Irving Medical Center, New York. During his tenure at Dr. Leal’s lab, he focused on the genetic basis of various rare diseases including skin, bone, neurological and hearing abnormalities. 

In May 2023, Dr. Liaqat accepted a new role within the Department of Medical and Molecular Genetics as a postdoctoral clinical genomic scientist with the Undiagnosed Rare Disease Clinic. His primary responsibilities include the interpretation of genetic sequence variation identified through diagnostic genetics testing or through the research pipelines, primarily using Next Generation Sequencing (WES, WGS, and RNA-seq) under the supervision of clinic directors Dr. Vetrini and Dr. Conboy. Dr. Liaqat is also involved in research projects that report novel gene discoveries, and variant reclassification and contribute to scientific publications.

He is also a recipient of the International Research Support Initiative Program (IRSIP) award from the Higher Education Commission (HEC) of Pakistan. In his free time, he enjoys traveling and spending time with his family in outdoor activities.

Dr. Schwantes-An is a genetic epidemiologist whose work focuses on understanding and identifying genetic underpinnings of complex human diseases. He received his PhD from Washington University in St. Louis and completed his postdoctoral training at the National Human Genome Research Institute at National Institutes of Health. He serves as a co-leader of bioinformatics team for Undiagnosed and Rare Disease Clinic. He is an assistant research professor in the Department of Medical and Molecular Genetics and in the Division of Cardiology in the Department of Medicine.

Marco Abreu studied biochemistry and chemical biotechnology at East Stroudsburg University in Pennsylvania, then studied bioinformatics at Virginia Commonwealth University in Virginia. He is currently a bioinformatician for the Department Medical and Molecular Genetics Department at IU School of Medicine. He enjoys serving his dog and cat overlords.

Dr. Graham obtained his MD and PhD from Emory University and then moved to Baylor College of Medicine and Texas Children’s Hospital for clinical residency training in pediatrics and clinical fellowship training in medical genetics. After a postdoctoral research fellowship, he joined the faculty of the Department of Molecular and Human Genetics at Baylor and rose through the ranks to associate professor, where he was an active member of BCM’s NIH Undiagnosed Disease Network team. He moved to Indianapolis in 2017 to join the Department of Medical and Molecular Genetics as an  associate professor and associate director of clinical genetics. Dr. Graham’s research laboratory is focused on studying mitochondrial biology and disease using models in both mouse and fruit fly. In his clinic, Dr. Graham evaluates and manages patients with medical genetic problems and inborn errors of metabolism.